Boston, MA, United States of America

Junichi Hanai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beth Israel Deaconess Medical Center, Inc., Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junichi Hanai. Retrieved from https://idiyas.com/inventor/junichi-hanai-9j0z09u8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junichi Hanai: Innovator in Cancer Research

Introduction

Junichi Hanai is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. His work focuses on developing innovative solutions to combat cancer chemoresistance, a major challenge in effective cancer treatment.

Latest Patents

Hanai holds a patent for "Compounds, pharmaceutical compositions, and methods of their use in reversing cancer chemoresistance." This patent describes various compounds and pharmaceutical compositions that aim to reverse the resistance of cancer cells to chemotherapy, potentially improving treatment outcomes for patients.

Career Highlights

Throughout his career, Junichi Hanai has worked with esteemed institutions such as The General Hospital Corporation and the Massachusetts Institute of Technology. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Mo Motamedi and Vikas P Sukhatme, who have also made significant contributions to cancer research. Their collaborative efforts have further advanced the understanding and treatment of cancer.

Conclusion

Junichi Hanai's innovative work in reversing cancer chemoresistance highlights his dedication to improving cancer treatment. His contributions to the field are invaluable and continue to inspire future research in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…